Taylor Wealth Management Partners Halozyme Therapeutics, Inc. Transaction History
Taylor Wealth Management Partners
- $176 Million
- Q2 2022
A detailed history of Taylor Wealth Management Partners transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Taylor Wealth Management Partners holds 78,071 shares of HALO stock, worth $4.13 Million. This represents 1.95% of its overall portfolio holdings.
Number of Shares
78,071
Previous 82,384
5.24%
Holding current value
$4.13 Million
Previous $3.29 Million
4.57%
% of portfolio
1.95%
Previous 1.33%
Shares
20 transactions
Others Institutions Holding HALO
# of Institutions
442Shares Held
122MCall Options Held
216KPut Options Held
140K-
Black Rock Inc. New York, NY18.2MShares$966 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$691 Million0.01% of portfolio
-
State Street Corp Boston, MA6.49MShares$344 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.12MShares$218 Million3.73% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.79MShares$201 Million0.24% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.38B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...